Takeover of Cubist Pharmaceuticals Inc (NASDAQ:CBST) Faces Investor Investigation
The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), was launched concerning whether the takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share is unfair to NASDAQ:CBST stockholders.
View full press release